About Quantitative Medicine
Quantitative Medicine is a company based in Pittsburgh (United States) founded in 2012 was acquired by Predictive Oncology in January 2020. Quantitative Medicine operates in a competitive market with competitors including Insitro, GSK, Avidity Biosciences, Vividion Therapeutics and HotSpot Therapeutics, among others.
- Headquarter Pittsburgh, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Predictive Oncology
(Jan 24, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Quantitative Medicine
Detailed funding history for Quantitative Medicine
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Quantitative Medicine
Quantitative Medicine has secured backing from 1 investor. Prominent investors backing the company include Predictive Oncology.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
AI-based platform for cancer diagnostics and precision medicine is utilized.
|
Locked | Locked | Locked |
Investor details for Quantitative Medicine
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Quantitative Medicine
Investment portfolio details for Quantitative Medicine
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Quantitative Medicine
Detailed financials for Quantitative Medicine
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Quantitative Medicine Comparisons
Peer comparison for Quantitative Medicine
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Quantitative Medicine
Quantitative Medicine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, GSK, Avidity Biosciences, Vividion Therapeutics and HotSpot Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
Developer of a platform for protein function analysis
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
Detailed competitors of Quantitative Medicine
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Quantitative Medicine
Complete news archive for Quantitative Medicine
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Quantitative Medicine
Quantitative Medicine was founded in 2012.
Quantitative Medicine is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Quantitative Medicine was founded in 2012 in Pittsburgh, United States, within the biomedical analytics and computational biology sector. A drug discovery platform is operated, by which drug candidates are screened against pathogenic, cellular, molecular, and systems biology targets. Similarities in target relationships are identified using active machine learning and predictive modeling. Efficiency in drug discovery processes is thereby enhanced, with operations centered in the United States.
Quantitative Medicine's top competitors include Insitro, Sutro Biopharma and Avidity Biosciences.
Quantitative Medicine has 1 investor. Key investors include Predictive Oncology.